Siemens names Gillen VP of MR division

Article

Siemens Medical Systems has announced the promotion of Nancy Gillen to vice president of its magnetic resonance division, with responsibility for marketing the company’s MR systems in the U.S. Gillen replaces John Pavlidis, who was named group vice

Siemens Medical Systems has announced the promotion of Nancy Gillen to vice president of its magnetic resonance division, with responsibility for marketing the company’s MR systems in the U.S. Gillen replaces John Pavlidis, who was named group vice president of Siemens’ ultrasound division, based in Issaquah, WA, last month (SCAN 2/16/00). Gillen has been national sales manager for the MR division in Iselin, NJ, since 1995. Prior to that she was product specialist for computed tomography. She joined Siemens in 1988 as a CT/MR sales specialist in the New York area.

In other news, Siemens Medical Engineering opened its new MR manufacturing and administration facility in Erlangen, Germany. About 2000 employees will work at the new site, which consolidates MR, special products, and components development and production. The company expects the new facility to produce up to 800 MR systems annually.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.